Nicolas Signolle

机构：Centre National de la Recherche Scientifique, Inserm, Université Paris-Saclay, Institut Gustave Roussy, Analyse moléculaire, modélisation et imagerie de la maladie cancéreuse · ORCID：0000-0001-6222-6003

发表论文 96 篇 · 总被引 1251 次 · h-index 18

代表论文

Patritumab deruxtecan in HR+HER2− advanced breast cancer: a phase 2 trial (2025 · Nature Medicine · 被引 23)
Tumor Purity as a Prognostic and Predictive Biomarker of Postoperative Radiation Therapy Outcomes in Stage IIIA-N2 Non-Small Cell Lung Cancer: A Transcriptomic Analysis From the Lung ART Trial (2026 · International Journal of Radiation Oncology*Biology*Physics · 被引 1)
Molecular analysis highlights TREM2 as a discriminating biomarker for patients suffering from pancreatic ductal adenocarcinoma (2025 · Cancer Treatment and Research Communications · 被引 1)
Data from TREM2-Expressing Multinucleated Giant Macrophages Are a Biomarker of Good Prognosis in Head and Neck Squamous Cell Carcinoma (2024 · 被引 1)
Spatial transcriptomic atlas of aggressive osteosarcomas reveals shared immune landscape and targetable surface markers (2026 · Nature Communications)
Figure S4 from TREM2-Expressing Multinucleated Giant Macrophages Are a Biomarker of Good Prognosis in Head and Neck Squamous Cell Carcinoma (2026)